drugset / Trial / NCT02230904
A Study to Compare the Adhesiveness of 2 Different Rotigotine Patches Used for the Treatment of Parkinson's Disease
Phase 1
Completed
57 enrolled
UCB BIOSCIENCES, Inc.
Bracket Global · collabPharmaceutical Health Sciences · collab
RandomizedCrossoverDouble-blindTreatment
Summary
The primary objective of the study is to compare the adhesiveness of 2 different patch formulations of Rotigotine using the largest patch size of 40 cm\^2, under the assumption that both patch formulations show similar adhesiveness properties.
Timeline
- Start
- 2014-09
- Primary completion
- 2014-11
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rotigotine | Unknown | 8 mg | Other |